225 related articles for article (PubMed ID: 378729)
1. Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
Majid PA; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
J Int Med Res; 1979; 7(3):194-200. PubMed ID: 378729
[TBL] [Abstract][Full Text] [Related]
2. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
Olowoyeye JO; Thadani U; Parker JO
Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.
Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB
Eur J Clin Pharmacol; 1987; 32(2):127-33. PubMed ID: 3556193
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adrenergic beta-receptor antagonists in angina pectoris.
Thadani U; Sharma B; Meeran MK; Majid PA; Whitaker W; Taylor SH
Br Med J; 1973 Jan; 1(5846):138-42. PubMed ID: 4145234
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
Jones GR; Mir MA
Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
[TBL] [Abstract][Full Text] [Related]
7. Comparison of adrenergic beta-blocking drugs in angina pectoris.
Sharma B; Meeran MK; Galvin MC; Tulpule AT; Whitaker W; Taylor SH
Br Med J; 1971 Jul; 3(5767):152-5. PubMed ID: 4397655
[TBL] [Abstract][Full Text] [Related]
8. Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departments.
Forrest WA
Curr Med Res Opin; 1978; 5(9):669-74. PubMed ID: 104825
[TBL] [Abstract][Full Text] [Related]
9. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Ravid M; Lang R; Jutrin I
Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effect of oxprenolol in angina pectoris: comparison with a placebo and propranolol by double blind assay].
Murakami M; Murakami E; Takekoshi J; Hayase S; Shintani H
Nihon Rinsho; 1973 Apr; 31(4):913-22. PubMed ID: 4580401
[No Abstract] [Full Text] [Related]
11. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness of slow-release propranolol (Inderal LA) 80, 160 and 320 mg orally daily in the treatment of angina pectoris.
Odemuyiwa O; Peart I; Alberts C; Hall RJ
Br J Clin Pract; 1990 Jan; 44(1):9-12. PubMed ID: 2317442
[TBL] [Abstract][Full Text] [Related]
13. Comparison of slow-release pindolol, standard pindolol, and propranolol in angina pectoris.
Parker JO
Am J Cardiol; 1983 Apr; 51(7):1062-6. PubMed ID: 6404149
[TBL] [Abstract][Full Text] [Related]
14. Effect on exercise tolerance and pharmacokinetics of conventional and sustained release preparations of propranolol in patients with angina pectoris--a double-blind cross-over study.
Kambara H; Kinoshita M; Hirota Y; Kadota K; Sawamura M; Saito T; Kawai C
Jpn Circ J; 1984 Oct; 48(10):1066-73. PubMed ID: 6387210
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
[TBL] [Abstract][Full Text] [Related]
16. Pre-dosing plasma concentrations and beta-adrenoceptor blocking effects during repeated once daily dosing with 160 mg sustained-release propranolol (Inderal LA) and 16/260 oxprenolol Oros to healthy volunteers.
Moppert J; Degen PH; Racine-Poon A
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):197S-201S. PubMed ID: 2988591
[TBL] [Abstract][Full Text] [Related]
17. Chronic stable angina: comparison of verapamil and propranolol.
Southall E; Nutt NR; Thomas RD
J Int Med Res; 1982; 10(5):361-6. PubMed ID: 6754509
[TBL] [Abstract][Full Text] [Related]
18. Once daily administration of sustained release propranolol capsules in the treatment of angina pectoris.
Halkin H; Vered I; Saginer A; Rabinowitz B
Eur J Clin Pharmacol; 1979; 16(6):387-91. PubMed ID: 393520
[No Abstract] [Full Text] [Related]
19. Slow release oxprenolol in angina pectoris [proceedings].
Goldstraw PW; Taylor SH; Thadani U; Watt SJ
Br J Clin Pharmacol; 1977 Jun; 4(3):387P. PubMed ID: 332219
[No Abstract] [Full Text] [Related]
20. Double-blind crossover clinical trial of oxyfedrine and propranolol in angina pectoris.
Sagar S; Pandhi P; Anand IS; Sharma PL; Wahi PL
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):186-9. PubMed ID: 3888857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
